Frozen shoulder and risk of cancer: a population-based cohort study.
Br J Cancer 2017;
117:144-147. [PMID:
28524156 PMCID:
PMC5520209 DOI:
10.1038/bjc.2017.146]
[Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Revised: 04/24/2017] [Accepted: 04/27/2017] [Indexed: 12/20/2022] Open
Abstract
Background:
Frozen shoulder might be a complication or a presenting symptom of cancer. We examined the risk of a cancer diagnosis after an incident diagnosis of frozen shoulder.
Methods:
We used prospectively collected data from Danish registries to identify patients with frozen shoulder during 1995–2013 and followed them for the development of cancer.
Results:
We observed 2572 incident cancers among 29 098 frozen shoulder patients. The expected number of incident cancers in the general population was 2434. The 6-month cumulative incidence of any cancer was 0.70%, corresponding to a standardised incidence ratio (SIR) of 1.38 (95% confidence interval (CI): 1.19–1.58). Risk increases were highest for lung cancer (SIR=2.19, 95% CI: 1.48–3.13), breast cancer (SIR=1.51, 95% CI: 1.02–2.15), and non-Hodgkin’s lymphoma (SIR=2.28, 95% CI: 1.09–4.20). The cumulative incidence of any cancer during the remainder of follow-up (>6 months to a maximum 18.9 years) was 24.8% with an SIR of 1.04 (95% CI: 1.00–1.08).
Conclusions:
Frozen shoulder might be an early predictor for a subsequent cancer diagnosis.
Collapse